Gyre Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:GYRE)

Financials

Cash from operating activities -55.05 M-83.75 M-33.1 M25.89 M-3.64 M1.01 M 4.32 M Cash from investing activities 9.66 M48.19 M55.43 M-19.76 M-19.88 M-474 K -5.5 M Cash from financing activities 60.38 M49.55 M-45.01 M2.5 M2.1 M24.38 M 23.05 M Free cash flow -55.05 M-83.75 M-33.1 M25.89 M-3.64 M-913 K 3.03 M